
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
Patient education has generally been provided during in-person clinical visits. While this practice is unlike to fade away completely, additional patient education materials have evolved as technology has become a bigger part of daily life. Mobile applications that focus on patient education can be effective tools to incorporate into clinical practice, so what exactly should clinicians consider before doing so? Equiva, a health relationship management platform, recently released a






